<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The insulin-like growth factors are a family of growth factors, binding proteins and receptors that are involved in <z:mpath ids='MPATH_458'>normal</z:mpath> growth as well as in a number of pathological states </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001548'>Overgrowth</z:hpo> syndromes are a group of disorders characterized by a phenotype of excessive somatic and visceral growth </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, patients suffering from <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndromes are predisposed to develop <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Several specific defects linked to the insulin-like growth factor system were elucidated for a group of these disorders, including <z:e sem="disease" ids="C0796154" disease_type="Disease or Syndrome" abbrv="SDYS">Simpson-Golabi-Behmel syndrome</z:e>, Bannayan-Ruvalcaba-Riley syndrome and <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this review is to examine recent data linking the phenotype of <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndromes, visceral growth and increased risk of <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, with the molecular machinery of the IGF system </plain></SENT>
</text></document>